<DOC>
	<DOCNO>NCT00345059</DOCNO>
	<brief_summary>The purpose study compare overall survival patient advance non small cell lung cancer treat docetaxel single therapy versus docetaxel combination either gemcitabine vinorelbine combination capecitabine .</brief_summary>
	<brief_title>The DISTAL-2 Study : Docetaxel Alone Combination Second-line Treatment Advanced Non Small-Cell Lung Cancer</brief_title>
	<detailed_description>This study patient previously diagnose advanced non small cell lung cancer ( NSCLC , stage IIIb IV ) progression disease first-line therapy contain platinum . Patients assign receive 6 cycle therapy one four treatment regimen : - docetaxel - docetaxel + vinorelbine - docetaxel + gemcitabine - docetaxel + capecitabine</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<criteria>Written inform consent Age &gt; 18 Histological diagnosis non smallcell lung cancer ( NSCLC ) Stage IIIb Stage IV disease ( IIIb , previous treatment chemotherapy + radiotherapy , metastatic supraclavicular lymph node pleural effusion ) Disease progression Previous chemotherapy platinumderivative ( &gt; 21 day last administration ) ECOG performance status &gt; 2 Age &gt; 75 year History malignant neoplasm within previous 5 year ( except baso spinocellular skin carcinoma insitu carcinoma uterine cervix , provide adequately treat ) Previous treatment docetaxel Presence symptomatic cerebral metastasis Neutrophils &lt; 2.0 x 109/l , platelet &lt; 100,000/l , hemoglobin &gt; 10g/dl Bilirubin &lt; 1.5 x upper normal limit SGOT , SGPT , bilirubin &gt; 1.25 x upper normal limit except presence hepatic metastasis Creatinine &gt; 1.25 x upper normal limit Any concomitant pathology would , Investigator 's opinion , contraindicate use drug protocol Inability comply follow Pregnant nursing female</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>second line</keyword>
	<keyword>monochemotherapy</keyword>
	<keyword>combination chemotherapy</keyword>
	<keyword>platinum refractory</keyword>
	<keyword>previously treat</keyword>
</DOC>